HEADER HYDROLASE 03-APR-25 9O2D TITLE HEPARANASE P6 IN COMPLEX WITH FRAGMENT J74 (L-NOREPINEPHRINE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPARANASE 50 KDA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEPARANASE 8 KDA SUBUNIT; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HEPARANASE, SMALL MOLECULE, CANCER, COMPLEX, THERAPEUTICS, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.J.DAVIES,R.L.FRKIC,C.J.JACKSON REVDAT 1 11-FEB-26 9O2D 0 JRNL AUTH L.J.DAVIES,C.WHITEFIELD,H.KIM,C.NITSCHE,C.J.JACKSON, JRNL AUTH 2 R.L.FRKIC JRNL TITL FRAGMENT SCREENING AND STRUCTURE-GUIDED DEVELOPMENT OF JRNL TITL 2 HEPARANASE INHIBITORS REVEAL ORTHOSTERIC AND ALLOSTERIC JRNL TITL 3 INHIBITION JRNL REF ACS MED.CHEM.LETT. 2026 JRNL REFN ISSN 1948-5875 JRNL DOI 10.1021/ACSMEDCHEMLETT.5C00587 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.21.2_5419: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 24588 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.830 REMARK 3 FREE R VALUE TEST SET COUNT : 1188 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.4400 - 4.6000 1.00 3096 159 0.1884 0.2483 REMARK 3 2 4.6000 - 3.6500 1.00 2969 129 0.1551 0.1638 REMARK 3 3 3.6500 - 3.1900 1.00 2937 142 0.1641 0.2332 REMARK 3 4 3.1900 - 2.9000 1.00 2905 145 0.2067 0.2673 REMARK 3 5 2.9000 - 2.6900 1.00 2895 135 0.2226 0.2775 REMARK 3 6 2.6900 - 2.5300 1.00 2854 179 0.2331 0.3228 REMARK 3 7 2.5300 - 2.4000 1.00 2883 149 0.2684 0.3396 REMARK 3 8 2.4000 - 2.3000 1.00 2861 150 0.2769 0.3158 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.030 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 NULL REMARK 3 ANGLE : 0.633 NULL REMARK 3 CHIRALITY : 0.042 556 REMARK 3 PLANARITY : 0.006 647 REMARK 3 DIHEDRAL : 15.010 1378 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9O2D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-APR-25. REMARK 100 THE DEPOSITION ID IS D_1000293767. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24648 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 47.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.20 REMARK 200 R MERGE (I) : 1.01100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 12.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 0.1 M AMMONIUM REMARK 280 ACETATE, 25% PEG4000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.29050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.70100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.10200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.70100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.29050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.10200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -112.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 260 60.03 -153.51 REMARK 500 THR A 333 -56.56 -134.40 REMARK 500 GLU A 343 118.27 -165.50 REMARK 500 SER A 345 -162.90 -162.16 REMARK 500 LEU A 355 -56.88 -142.06 REMARK 500 LEU A 419 -152.62 -105.40 REMARK 500 ASP A 427 155.60 79.74 REMARK 500 ARG A 429 -102.35 -126.23 REMARK 500 SER B 55 39.05 -89.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 917 DISTANCE = 14.83 ANGSTROMS REMARK 525 HOH B 333 DISTANCE = 6.35 ANGSTROMS DBREF 9O2D A 160 543 UNP Q9Y251 HPSE_HUMAN 160 543 DBREF 9O2D B 36 109 UNP Q9Y251 HPSE_HUMAN 36 109 SEQADV 9O2D LYS A 178 UNP Q9Y251 ASN 178 CONFLICT SEQADV 9O2D SER A 195 UNP Q9Y251 ALA 195 CONFLICT SEQADV 9O2D GLY A 197 UNP Q9Y251 LEU 197 CONFLICT SEQADV 9O2D ALA A 212 UNP Q9Y251 SER 212 CONFLICT SEQADV 9O2D ASP A 219 UNP Q9Y251 SER 219 CONFLICT SEQADV 9O2D ARG A 230 UNP Q9Y251 LEU 230 CONFLICT SEQADV 9O2D GLY A 234 UNP Q9Y251 ASP 234 CONFLICT SEQADV 9O2D LYS A 244 UNP Q9Y251 GLU 244 CONFLICT SEQADV 9O2D HIS A 248 UNP Q9Y251 GLN 248 CONFLICT SEQADV 9O2D GLY A 273 UNP Q9Y251 ARG 273 CONFLICT SEQADV 9O2D ALA A 292 UNP Q9Y251 SER 292 CONFLICT SEQADV 9O2D LEU A 307 UNP Q9Y251 LYS 307 CONFLICT SEQADV 9O2D THR A 318 UNP Q9Y251 ILE 318 CONFLICT SEQADV 9O2D GLN A 322 UNP Q9Y251 SER 322 CONFLICT SEQADV 9O2D LEU A 327 UNP Q9Y251 PHE 327 CONFLICT SEQADV 9O2D GLY A 354 UNP Q9Y251 LEU 354 CONFLICT SEQADV 9O2D GLN A 426 UNP Q9Y251 SER 426 CONFLICT SEQADV 9O2D ASP A 427 UNP Q9Y251 LYS 427 CONFLICT SEQADV 9O2D GLN A 477 UNP Q9Y251 LYS 477 CONFLICT SEQADV 9O2D HIS A 483 UNP Q9Y251 LEU 483 CONFLICT SEQADV 9O2D ASP A 486 UNP Q9Y251 HIS 486 CONFLICT SEQADV 9O2D GLN A 498 UNP Q9Y251 LEU 498 CONFLICT SEQADV 9O2D LYS A 512 UNP Q9Y251 MET 512 CONFLICT SEQADV 9O2D PRO A 513 UNP Q9Y251 GLU 513 CONFLICT SEQADV 9O2D ALA A 530 UNP Q9Y251 SER 530 CONFLICT SEQADV 9O2D PRO A 540 UNP Q9Y251 ALA 540 CONFLICT SEQRES 1 A 384 PHE LYS ASN SER THR TYR SER ARG SER SER VAL ASP VAL SEQRES 2 A 384 LEU TYR THR PHE ALA LYS CYS SER GLY LEU ASP LEU ILE SEQRES 3 A 384 PHE GLY LEU ASN ALA LEU LEU ARG THR SER ASP GLY GLN SEQRES 4 A 384 TRP ASN SER SER ASN ALA GLN LEU LEU LEU ASP TYR CYS SEQRES 5 A 384 ALA SER LYS GLY TYR ASN ILE ASP TRP GLU LEU GLY ASN SEQRES 6 A 384 GLU PRO ASN SER PHE ARG LYS LYS ALA GLY ILE PHE ILE SEQRES 7 A 384 ASN GLY SER GLN LEU GLY LYS ASP PHE ILE HIS LEU HIS SEQRES 8 A 384 LYS LEU LEU ARG LYS SER THR PHE LYS ASN ALA LYS LEU SEQRES 9 A 384 TYR GLY PRO ASP VAL GLY GLN PRO ARG GLY LYS THR ALA SEQRES 10 A 384 LYS MET LEU LYS SER PHE LEU LYS ALA GLY GLY GLU VAL SEQRES 11 A 384 ILE ASP ALA VAL THR TRP HIS HIS TYR TYR LEU ASN GLY SEQRES 12 A 384 ARG THR ALA THR LEU GLU ASP PHE LEU ASN PRO ASP VAL SEQRES 13 A 384 LEU ASP THR PHE ILE SER GLN VAL GLN LYS VAL LEU GLN SEQRES 14 A 384 VAL VAL GLU SER THR ARG PRO GLY LYS LYS VAL TRP LEU SEQRES 15 A 384 GLY GLU THR SER SER ALA TYR GLY GLY GLY ALA PRO GLY SEQRES 16 A 384 LEU SER ASP THR PHE ALA ALA GLY PHE MET TRP LEU ASP SEQRES 17 A 384 LYS LEU GLY LEU SER ALA ARG MET GLY ILE GLU VAL VAL SEQRES 18 A 384 MET ARG GLN VAL PHE PHE GLY ALA GLY ASN TYR HIS LEU SEQRES 19 A 384 VAL ASP GLU ASN PHE ASP PRO LEU PRO ASP TYR TRP LEU SEQRES 20 A 384 SER LEU LEU PHE LYS LYS LEU VAL GLY THR LYS VAL LEU SEQRES 21 A 384 MET ALA SER VAL GLN GLY GLN ASP ARG ARG LYS LEU ARG SEQRES 22 A 384 VAL TYR LEU HIS CYS THR ASN THR ASP ASN PRO ARG TYR SEQRES 23 A 384 LYS GLU GLY ASP LEU THR LEU TYR ALA ILE ASN LEU HIS SEQRES 24 A 384 ASN VAL THR LYS TYR LEU ARG LEU PRO TYR PRO PHE SER SEQRES 25 A 384 ASN LYS GLN VAL ASP GLN TYR LEU LEU ARG PRO HIS GLY SEQRES 26 A 384 PRO ASP GLY LEU LEU SER LYS SER VAL GLN LEU ASN GLY SEQRES 27 A 384 GLN THR LEU LYS MET VAL ASP ASP GLN THR LEU PRO PRO SEQRES 28 A 384 LEU LYS PRO LYS PRO LEU ARG PRO GLY SER SER LEU GLY SEQRES 29 A 384 LEU PRO ALA PHE SER TYR ALA PHE PHE VAL ILE ARG ASN SEQRES 30 A 384 ALA LYS VAL PRO ALA CYS ILE SEQRES 1 B 74 GLN ASP VAL VAL ASP LEU ASP PHE PHE THR GLN GLU PRO SEQRES 2 B 74 LEU HIS LEU VAL SER PRO SER PHE LEU SER VAL THR ILE SEQRES 3 B 74 ASP ALA ASN LEU ALA THR ASP PRO ARG PHE LEU ILE LEU SEQRES 4 B 74 LEU GLY SER PRO LYS LEU ARG THR LEU ALA ARG GLY LEU SEQRES 5 B 74 SER PRO ALA TYR LEU ARG PHE GLY GLY THR LYS THR ASP SEQRES 6 B 74 PHE LEU ILE PHE ASP PRO LYS LYS GLU HET PEG A 601 7 HET PEG A 602 7 HET SO4 A 603 5 HET SO4 A 604 5 HET SO4 A 605 5 HET SO4 A 606 5 HET SO4 A 607 5 HET LNR B 201 12 HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM SO4 SULFATE ION HETNAM LNR L-NOREPINEPHRINE HETSYN LNR NORADRENALINE FORMUL 3 PEG 2(C4 H10 O3) FORMUL 5 SO4 5(O4 S 2-) FORMUL 10 LNR C8 H11 N O3 FORMUL 11 HOH *250(H2 O) HELIX 1 AA1 SER A 166 SER A 180 1 15 HELIX 2 AA2 SER A 201 LYS A 214 1 14 HELIX 3 AA3 GLU A 225 ASN A 227 5 3 HELIX 4 AA4 SER A 228 GLY A 234 1 7 HELIX 5 AA5 ASN A 238 SER A 256 1 19 HELIX 6 AA6 GLY A 273 GLY A 287 1 15 HELIX 7 AA7 THR A 306 ASN A 312 1 7 HELIX 8 AA8 ASN A 312 SER A 332 1 21 HELIX 9 AA9 THR A 358 ALA A 360 5 3 HELIX 10 AB1 ALA A 361 GLY A 376 1 16 HELIX 11 AB2 LEU A 401 LEU A 413 1 13 HELIX 12 AB3 PRO A 469 LYS A 473 5 5 HELIX 13 AB4 ASP A 486 SER A 490 5 5 HELIX 14 AB5 VAL A 539 ILE A 543 5 5 HELIX 15 AB6 ASN B 64 ASP B 68 5 5 HELIX 16 AB7 ARG B 70 LEU B 75 1 6 HELIX 17 AB8 SER B 77 LEU B 87 1 11 HELIX 18 AB9 GLY B 96 ASP B 100 5 5 SHEET 1 AA1 2 SER A 163 TYR A 165 0 SHEET 2 AA1 2 LEU B 102 PHE B 104 1 O ILE B 103 N SER A 163 SHEET 1 AA2 9 LEU A 182 LEU A 188 0 SHEET 2 AA2 9 ASP A 219 LEU A 222 1 O ASP A 219 N PHE A 186 SHEET 3 AA2 9 LEU A 263 VAL A 268 1 O TYR A 264 N TRP A 220 SHEET 4 AA2 9 ALA A 292 HIS A 297 1 O HIS A 296 N VAL A 268 SHEET 5 AA2 9 LYS A 338 THR A 344 1 O TRP A 340 N VAL A 293 SHEET 6 AA2 9 ILE A 377 ARG A 382 1 O MET A 381 N LEU A 341 SHEET 7 AA2 9 LEU B 57 ASP B 62 1 O SER B 58 N ARG A 382 SHEET 8 AA2 9 ALA B 90 GLY B 95 1 O ARG B 93 N VAL B 59 SHEET 9 AA2 9 LEU A 182 LEU A 188 1 N ASP A 183 O LEU B 92 SHEET 1 AA3 2 LEU A 300 ASN A 301 0 SHEET 2 AA3 2 ALA A 347 TYR A 348 1 O TYR A 348 N LEU A 300 SHEET 1 AA4 4 GLN A 498 THR A 499 0 SHEET 2 AA4 4 VAL A 493 LEU A 495 -1 N LEU A 495 O GLN A 498 SHEET 3 AA4 4 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA4 4 LYS A 514 LEU A 516 -1 O LEU A 516 N VAL A 475 SHEET 1 AA5 8 GLN A 498 THR A 499 0 SHEET 2 AA5 8 VAL A 493 LEU A 495 -1 N LEU A 495 O GLN A 498 SHEET 3 AA5 8 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA5 8 SER A 528 ILE A 534 -1 O VAL A 533 N ASP A 476 SHEET 5 AA5 8 LEU A 450 ASN A 456 -1 N LEU A 452 O PHE A 532 SHEET 6 AA5 8 LEU A 431 THR A 438 -1 N HIS A 436 O THR A 451 SHEET 7 AA5 8 VAL A 414 VAL A 418 -1 N LYS A 417 O CYS A 437 SHEET 8 AA5 8 HIS B 50 LEU B 51 -1 O HIS B 50 N VAL A 418 SHEET 1 AA6 4 MET A 420 VAL A 423 0 SHEET 2 AA6 4 VAL B 38 PHE B 44 -1 O ASP B 42 N SER A 422 SHEET 3 AA6 4 LYS A 462 ARG A 465 1 N ARG A 465 O VAL B 39 SHEET 4 AA6 4 LEU A 522 LEU A 524 -1 O LEU A 522 N LEU A 464 SSBOND 1 CYS A 437 CYS A 542 1555 1555 2.03 CISPEP 1 GLY A 265 PRO A 266 0 2.96 CISPEP 2 GLN A 383 VAL A 384 0 -9.98 CISPEP 3 TYR A 468 PRO A 469 0 2.53 CISPEP 4 SER B 88 PRO B 89 0 -1.62 CRYST1 58.581 74.204 123.402 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017070 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013476 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008104 0.00000 CONECT 2199 3031 CONECT 3031 2199 CONECT 3629 3630 3631 CONECT 3630 3629 CONECT 3631 3629 3632 CONECT 3632 3631 3633 CONECT 3633 3632 3634 CONECT 3634 3633 3635 CONECT 3635 3634 CONECT 3636 3637 3638 CONECT 3637 3636 CONECT 3638 3636 3639 CONECT 3639 3638 3640 CONECT 3640 3639 3641 CONECT 3641 3640 3642 CONECT 3642 3641 CONECT 3643 3644 3645 3646 3647 CONECT 3644 3643 CONECT 3645 3643 CONECT 3646 3643 CONECT 3647 3643 CONECT 3648 3649 3650 3651 3652 CONECT 3649 3648 CONECT 3650 3648 CONECT 3651 3648 CONECT 3652 3648 CONECT 3653 3654 3655 3656 3657 CONECT 3654 3653 CONECT 3655 3653 CONECT 3656 3653 CONECT 3657 3653 CONECT 3658 3659 3660 3661 3662 CONECT 3659 3658 CONECT 3660 3658 CONECT 3661 3658 CONECT 3662 3658 CONECT 3663 3664 3665 3666 3667 CONECT 3664 3663 CONECT 3665 3663 CONECT 3666 3663 CONECT 3667 3663 CONECT 3668 3669 CONECT 3669 3668 3670 3671 CONECT 3670 3669 3675 CONECT 3671 3669 3672 3673 CONECT 3672 3671 CONECT 3673 3671 3674 CONECT 3674 3673 3675 CONECT 3675 3670 3674 3676 CONECT 3676 3675 3677 3678 CONECT 3677 3676 CONECT 3678 3676 3679 CONECT 3679 3678 MASTER 240 0 8 18 29 0 0 6 3921 2 53 36 END